Clinical Trial

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 12, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the safety and efficacy of DEB-TACE with visualable embolization microspheres versus PVA microspheres for hepatocellular carcinoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-19.
Trial Details
NCT Number NCT06190665
Lead Sponsor Zhongda Hospital
Conditions Hepatocellular Carcinoma
Enrollment 188 participants
Start Date 2023-12-19
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-12